IRCT20220209053979N7已完成Unknown
Bioequivalence Study of desloratadine 5 mg manufactured by Pharma Chemi and Clarinex manufactured by Schering in 24 Healthy Volunteers under fasting condition
Pharmachemi Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Healthy male or female volunteers between the age of 18 and 55 with a body mass index (BMI) between 19 and 30
- •volunteers who are willing to sign an informed consent form
排除标准
- •History of allergy to desloratadine or formulation components
- •History or significant clinical evidence of any disease
- •Taking any type of medicine in the 14 days before the start of the study
- •Participation in any clinical study within 30 days prior to study initiation
研究者
相似试验
尚未招募
不适用
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N40Darou darman Pars Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N60Actover Pharmaceutical Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Desloratadine 5 mg Tablet formulations.IRCT20180620040164N61Darou darman Arang24
尚未招募
不适用
Study of absorption and elimination rate of Desloratadine 5-mg tablets in comparison with Desloratadine brand tablets (Clarinex®).IRCT20200407046981N50Behestan Pharmaceutical Company24
进行中（未招募）
不适用
Combined treatment of cinnarizine and iprazochrome in urticaria factitiaEUCTR2012-004002-10-HUDepartment of Dermatology and Allergology, University of Szeged